Jacob White

[email protected]

LATEST

Building Stronger Sponsor and CDMO Partnerships through Clear Communication 
By

By
In pharmaceutical outsourcing, technical expertise and contract terms matter, but communication often determines whether a project meets its timelines, budget, and development goals. According to Allison Vavala, Senior Director of…

Novo, Orbis Medicines in $1.4-Bn Oral Macrocylic Cardiometabolic Disease Pact; Forms AI Drug-Discovery Pact with Anthropic 
By

By
Novo (formerly called Novo Nordisk) and Orbis Medicines, a Copenhagen, Denmark-based company specializing in oral macrocycle drug discovery, have entered an agreement to discover and develop oral macrocycle therapeutics for…

Roche, Dualitas in $1-Bn Bispecific Antibody Immunology & Inflammation Disease Pact
By

By
Roche and Dualitas Therapeutics, a South San Francisco, California-based bio/pharmaceutical company focused on bispecific antibody therapies for immunology and inflammation (I&I) indications, have entered an agreement to advance bispecific antibodies…

Supplier News: Evonik, Hovione, Lonza & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Evonik, Hovione, Lonza, Neuland Laboratories, European RNA Alliance, Argonaut, Bend Bioscience, Symbiosis, Ecolab and Piramal Pharma Solutions.   Chemicals/Chemical API Manufacturing * Neuland Laboratories…

Global Briefs: Novartis, GSK, Sanofi & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Novartis, Reckitt, Eli Lilly and Company, GSK, Sanofi, Legend Biotech, Chiesi, Takeda, and Gilead Sciences. Highlights below.   For…

Biotech Briefs: Luma Group, Electra Therapeutics, Sling Therapeutics, Kura Oncology & More 
By

By
The latest from small and Emerging Pharma companies featuring Luma Group, Electra Therapeutics, Sling Therapeutics, Kura Oncology, Schrodinger, and Adarx Pharmaceuticals.  For news on the large and mid-sized bio/pharmaceutical companies,…

Next-generation pMDIs: Embedding sustainability across design and development

The first low carbon pressurised Metered Dose Inhaler (pMDI) has hit the market, with more in development. These incorporate next-generation low Global Warming Potential (GWP) propellants that greatly reduce the…

HHS Names Acting Heads of CDER, CBER To Permanent Roles; Names FDA’s First Deputy Commissioner for Technology & AI 
By

By
In a move to solidify leadership positions at the US Food and Drug Administration (FDA), the US Department of Health and Human Services (HHS) has named the Acting Heads of…

AbbVie Completes $10.9-Bn Acquisition of Apogee Therapeutics 
By

By
AbbVie has completed its $10.9-billion acquisition of Apogee Therapeutics, a Waltham, Massachusetts-based clinical-stage bio/pharmaceutical company.   Apogee’s lead assets are zumilokibart, a subcutaneous half-life extended monoclonal antibody for treating atopic dermatitis…

Curia Opens $200-M Fill-Finish Expansion 
By

By
Curia, a CDMO of drug substances and drug products, has opened a $200-million expansion of its campus in Albuquerque, New Mexico. The expanded Albuquerque campus specializes in aseptic fill–finish and…